Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05483634

Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

Sponsor: Mackay Memorial Hospital

View on ClinicalTrials.gov

Summary

The definition of Genitourinary Syndrome of Menopause (GSM) is the decline of estrogens during menopause results in symptoms and clinical signs from both systems. Estrogen and other hormones production decrease after menopause because the ovaries lose their effectiveness, leading to mucosal atrophy, reduced vaginal moisture, dysuria, urgency, recurrent infection, burning, pruritus and dyspareunia. The treatment included vaginal estrogen supplement, vaginal hyaluronic acid supplement, vaginal laser, platelet rich plasma, etc. Observational cohort study will be used for study design, and questionnaire, pelvic examination, vaginal pap smear with maturation index (MI), vaginal pH, and other methods will be used for evaluation of the effectiveness and side effects.

Official title: Compare the Effectiveness and Side Effects of Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

Key Details

Gender

FEMALE

Age Range

45 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

40

Start Date

2025-12-01

Completion Date

2027-06-30

Last Updated

2025-05-09

Healthy Volunteers

No

Interventions

DRUG

Vaginal estrogen supplement

Daily vaginal estrogen supplement, then twice per week. Continue for three months.

PROCEDURE

Platelet-rich plasma injection

Monthly platelet-rich plasma injection for three months

Locations (1)

MacKay Memorial Hospital

Taipei, Taiwan